Rapp J P, Sustarsic D L, McPartland R P, Batten C L
Endocrinology. 1984 Mar;114(3):951-6. doi: 10.1210/endo-114-3-951.
The effects of various hormones on the urinary excretion of kallikrein and esterase A2 were studied in rats. Chronic treatment with antidiuretic hormone had no effect on the excretion of either enzyme. Deoxycorticosterone treatment or a low sodium diet stimulated urinary kallikrein excretion (as is well known), but had no effect on urinary esterase A2. Dexamethasone markedly suppressed the excretion of both kallikrein and esterase A2 and increased the excretion of proteins (inhibitors) that bind to each of these enzymes. It is likely that the suppressive effect of glucocorticoid on urinary kallikrein and esterase A2 activities is due to the increase in urinary binding proteins. There is also a strong correlation between the excretion of kallikrein and esterase A2 in normal untreated rats. Such a correlation might arise from a common effect of glucocorticoid-influenced inhibitors on both enzymes.
研究了各种激素对大鼠尿中激肽释放酶和酯酶A2排泄的影响。用抗利尿激素进行慢性治疗对两种酶的排泄均无影响。脱氧皮质酮治疗或低钠饮食可刺激尿激肽释放酶排泄(众所周知),但对尿酯酶A2无影响。地塞米松显著抑制激肽释放酶和酯酶A2的排泄,并增加与这些酶结合的蛋白质(抑制剂)的排泄。糖皮质激素对尿激肽释放酶和酯酶A2活性的抑制作用可能是由于尿结合蛋白增加所致。在未治疗的正常大鼠中,激肽释放酶和酯酶A2的排泄之间也存在很强的相关性。这种相关性可能源于糖皮质激素影响的抑制剂对这两种酶的共同作用。